Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...